📢 Save the Date! 📢 We’re excited to welcome our community back to Harvard Medical School on October 20-21 for the 2025 Biomarkers of Aging Conference! 🌟 Expect another year of a stellar lineup featuring academic, industry, and regulatory leaders at the forefront of translational geroscience. From academia to regulatory discussions, the event will showcase cutting-edge advancements in academic, translational, and industry science. 🔜 Our 2025 Conference website will be live soon. In the meantime, stay updated by subscribing to our Consortium newsletter for: 🔹 Key Conference updates 🔹 Exclusive content 🔹 Access to super early-bird tickets 🔹 And lots more 📩 Join today: We look forward to welcoming you back this October. 🙏 P.S. A big thank you to everyone who shared their thoughts in our 2024 Conference survey. As an open community of geroscience solvers, your feedback has been key in shaping the content and activities for this year's event.

☀️ We're gearing up to head to sunny California to co-host the Longevity Science Conference at Vitalist Bay (@VitalistBay) alongside our good friends at Vitalist from April 12-13! 🔬 Agenda: diving into the frontiers of longevity R&D including, 🔹 Biomarkers of aging 🔹 Partial reprogramming & cellular rejuvenation 🔹 Damage repair & gerotherapeutics 🔹 Clinical translation & regulatory hurdles 🔹 And much more Our conference features short, sharp talks, hands-on workshops, and open discussions in order to bridge the gap between labs, biotechs, and clinics in a collaborative setting and is part of Week 2 of the 8-week Vitalist Bay Longevity Zone, where each week explores a new perspective on aging science. Expect fantastic discussions with top scientists, leaders, and innovators tackling aging from all angles 🎤 Speakers include: Caitlin Lewis (@LongevityEVF), Peter Fedichev (@fedichev), Alejandro Ocampo (@aocampox), Marco Quarta (@MarcoQuarta12), Martin Borch Jensen (@MartinBJensen), Daniel Ives (@dives86), Mahdi Moqri (@mahdi_moqri), Vittorio Sebastiano (@SebastianoLab), Vera Gorbunova, Michael Conboy, Kevin Perrott (@kevinperrott), Alan Tomusiak (@alantomusiak), Eleanor Sheekey (@EleanorSheekey), Yuri Deigin (@ydeigin), Keshav K Singh (@mitoscientist), and many more to be announced soon. 🌱 Why attend? 🔹 Workshops to turn ideas into action 🔹 Networking with top minds in biotech + academia 🔹 Lively debates on ethics & innovation 🔹 Great weather and vibes 📍 Berkeley, CA | April 12-13, 2025 🎟 Tickets: 🚨 Get $100 off with the code EARLY100 - valid for the next 24 hours. We look forward to seeing many of you there!

@adamgries Looking forward to it! 💪

RT @adamgries: 1/ 📣Registration is open for the Longevity Science Conference (April 12-13, Berkeley) @ Vitalist Bay! Co-organized w/ @Agin…

What role does the immune system play in aging and chronic disease? This week, we’re featuring Dr. David Furman (@Furman_Lab), Director of the Stanford 1,000 Immunomes Project and Director of Buck Institute's AI and Bioinformatics Platform, as part of our highlights from the 2024 Biomarkers of Aging Conference. David’s talk sheds light on immunological biomarkers of aging and explores how inflammaging—the intersection of inflammation and aging—contributes to the development of chronic diseases. He also discusses recent progress in measuring functional aging rates and modeling disease through the lens of immune system aging. 🎥 Watch David Furman’s full talk here: Key topics covered include: 🔹 Immunological biomarkers of aging 🔹 The impact of inflammaging on chronic disease 🔹 Functional aging rates and modeling aging-disease links We’re gearing up for the 2025 Biomarkers of Aging Conference at Harvard Medical School, happening October 20–21. Stay updated on the latest advancements in aging science by subscribing to our newsletter:

Can volatile organic compounds (VOCs) provide a new lens for understanding aging? This week, we’re spotlighting Prof. Alexandra Stolzing’s pioneering research from the 2024 Biomarkers of Aging Conference. Alexandra’s work examines how VOCs - measured from breath and cell culture - can serve as biomarkers for disease detection, frailty, and resilience, paving the way for innovative diagnostic and therapeutic tools in aging science. 🎥 Watch the full talk here: Key topics covered include: 🔹 Using VOCs for disease detection and frailty biomarker development 🔹 Advances in breath VOC sampling and automated sample analysis 🔹 The VOC Library containing over 1,000 compounds 🔹 Mechanisms of action and automatic VOC recognition P.S. We're back for our 2025 Biomarkers of Aging Conference at Harvard Medical School from October 20 - 21! Stay updated by subscribing to our Consortium newsletter at

We're excited to partner with the Global Alzheimer's Platform Foundation (@GAP_Foundation) to accelerate the investigation of biomarkers of Alzheimer's disease and related dementias (ADRD) 🧠🎯 Our collaboration grants early access to Bio-Hermes-001 data, supporting efforts to improve diagnosis, prognosis, and treatments. “Large scale biomarker data, in particular blood biomarkers, from leading diagnostic and molecular assay companies, as collected and curated by Bio-Hermes-001 will enable validation and discovery of novel biomarkers of age-related diseases that reduces barriers to access to timely diagnosis for everyone.“ Mahdi Moqri (@mahdi_moqri), founding Co-Director of the Consortium. With large-scale biomarker insights, including diverse community representation, this partnership has the potential to drive significant progress in age-related neurodegenerative disease research. 🔗 Learn more in this press release: About the Global Alzheimer’s Platform Foundation (GAP): The nonprofit Global Alzheimer’s Platform Foundation was founded to speed the delivery of Alzheimer’s treatments with a commitment to promoting diversity in clinical research, as well as lowering the cost and improving the efficacy of ADRD clinical trials to ensure that no one is left behind. As part of its mission, GAP supports more than 100 clinical research sites worldwide through study start-up and recruitment activities, promoting diversity in research studies, and giving attention to the citizen scientists who make research possible.

Our friends at LBF are a visionary group of innovators driving progress in tackling aging head-on. Cohort 6 of their Longevity Biotech Fellowship is now accepting applications. Details below 👇

What can biomarkers tell us about how healthy behaviors influence biological aging? This week, we’re featuring Dr. John Earls, Senior AI Scientist at the Buck Institute for Research on Aging (@BuckInstitute), as part of our ongoing highlights from the 2024 Biomarkers of Aging Conference. John’s talk explores the mechanisms of biological aging, the variability of aging rates, and how wellness behaviors can improve biological age. His research bridges AI and multi-omic data to uncover actionable insights for optimizing health and longevity. 🎥 Watch the full talk here: Key topics covered include: 🔹 How biological age reflects wellness 🔹 The variability of aging rates based on initial health status 🔹 The role of healthy behaviors in improving biological age P.S. We're back for our 2025 Biomarkers of Aging Conference at Harvard Medical School from October 20-21! Stay updated by subscribing to our Consortium newsletter at

As part of our weekly highlight of talks from the 2024 Conference, this week we’re featuring Dr. Lynne Cox (@OxAgeN_oxford) Program Director of the Dynamic Resilience Program at Wellcome Leap (@WellcomeLeap). In her talk, Lynne introduces Wellcome Leap’s bold and unconventional approach to advancing human health by funding ambitious, large-scale programs. She emphasizes their focus on biomarkers of resilience and their clinical translation through the Dynamic Resilience (DR) Program. 🎥 Watch Lynne Cox’s full talk here: Key topics covered include: 🔹 The importance of resilience in health and aging 🔹 Identifying and validating biomarkers of resilience in humans 🔹 The goals and global scope of the DR Program 🔹 Tools needed to measure dynamic resilience P.S. We're back for our 2025 Biomarkers of Aging Conference at Harvard Medical School from October 20–21! Our Conference website will be live soon. Stay updated by subscribing to our Consortium newsletter at

@j_n_justice @xprize @SOLVEFSHD @hevolution_f Amazing 🤩

With the 2024 Biomarkers of Aging Conference now behind us and the 2025 conference scheduled for October 20–21, we’re excited to share the Day 2 recordings from last year’s event. Starting this week, we’ll spotlight talks from our outstanding lineup of speakers, highlighting their significant contributions to the fields of aging biomarkers and longevity interventions. We’re kicking off with Dr. Mahdi Moqri (@mahdi_moqri), Executive Co-Director of the Biomarkers of Aging Consortium, who provides a high-level recap of the confidential discussions from Day 1 of the conference. These discussions were designed to encourage open dialogue and the sharing of unpublished research, fostering a secure and collaborative environment for advancing scientific exchange. 🎥 Watch the full recap of Mahdi's talk here: Key topics covered included: 🔹 Omics & Multi-Omics Biomarkers of Aging 🔹 Molecular, Digital & Physiological Biomarkers 🔹 Systems Aging 🔹 Longitudinal & Clinical Biomarkers P.S. We're back for our 2025 Biomarkers of Aging Conference at Harvard Medical School from October 20-21! Our Conference website will be live soon, and in the meantime, stay updated by subscribing to our Consortium newsletter at

We're excited to welcome David Furman (@Furman_Lab) to our 2025 Scientific Advisory Board! Prof. Furman is an academic and entrepreneur, specializing in advanced statistics, artificial intelligence, and machine learning for translational medicine. As the Director of the Stanford (@Stanford) 1,000 Immunomes Project and an Associate Professor at the Buck Institute for Research on Aging (@BuckInstitute), his research focuses on the immune system's involvement in aging and age-related diseases. By employing advanced artificial intelligence and machine learning techniques, Dr. Furman analyzes large-scale immune system data to identify immunological biomarkers that predict health outcomes and potential therapeutic targets. His work highlights the role of systemic chronic inflammation, or inflammaging, in driving chronic diseases such as cardiovascular conditions, cancer, and neurodegenerative disorders. This research is critical for advancing our understanding of aging mechanisms, biomarkers of inflammaging, and developing interventions to extend healthspan and reduce the burden of age-related diseases. Learn more about our 2025 Leadership Team here:

🧵 4/4 Read the full, unlocked Nature Comment made available by the Consortium here:

THANK YOU ALL 🙏 for being part of this incredible journey to establish reliable biomarkers of aging for longevity interventions. It’s been a fantastic year, and we look forward to building on our success in 2025! See you next year! ❤️‍🔥

RT @scientistsorg: The world is aging. Today, some two thirds of the global population is dying from an age-related condition. By 2029, th…

@LaroccaDana @RaianyRomanni Wonderful publication, Raiany!